We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

NGENF

OTC
3.75400 USD
0.196
4.96%
Last update May 23, 3:59 PM EDT
Market closed
Day range
3.53000
4.22000
Previous close
3.95000
Open
3.92500
Access this stock data via API
Subscribe
NervGen Pharma Corp.
3.75
0.20
4.96%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 3.1M 4.6M 4.4M 3.8M
Selling general and admin 2.9M 2.2M 2.8M 2.2M
Other operating expenses
Operating income -6.0M -6.8M -7.2M -6.0M
Non operating interest income
Income 107.8K 171.1K 243.7K 294.9K
Expense
Other income expense 2.0M -2.0M 1.7M -2.1M
Pretax income -3.9M -8.6M -5.2M -7.8M
Tax provision
Net income -3.9M -8.6M -5.2M -7.8M
Basic EPS -0.1 -0.1 -0.1
Diluted EPS -0.1 -0.1 -0.1
Basic average shares 70.7M 70.1M 70.0M
Diluted average shares 70.7M 70.1M 70.0M
EBITDA -8.0M -4.8M -8.8M -3.9M
Net income from continuing op. -3.9M -8.6M -5.2M -7.8M
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 2 days 19 hours 17 minutes

10:42
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
06:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).